Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples